Associate Director, Field Medical Affairs – Australia & New Zealand

Our culture is entrepreneurial, inclusive and caring. We're passionate about our work. And we embrace a pioneering spirit. Join us as we strive to develop innovative therapies with the power to give people with genetic diseases freedom for life.

Job Summary

The Mission of the MSL Team and the Associate Director, Field Medical Affairs is to be the trusted scientific partners in the field for external experts and decision-makers. They will engage in scientific exchanges, accelerate data dissemination, and facilitate further AVROBIO engagement as appropriate. They will enhance the understanding of the scientific and medical value of our products in the therapeutic area and gather new patient and HCP insights. They will support cross-functional partners on clinical development, launch and commercial stage activities.  

Associate Director, Field Medical Affairs– Australia & New Zealand Region will be responsible for

  • Providing non-promotional scientific, educational, and research support for the lysosomal storage disorder (LSD) portfolio 
  • Developing and maintaining relationships with key LSD experts and treatment centers
  • Building a well-informed advocacy base
  • Act as a conduit for providing accurate and updated clinical, scientific and medical information to LSD Experts, health care professionals, treatments decision-makers and other members of the scientific, provider and payer community (private insurance, payers, medical groups, government agencies, and health systems with drug formularies), in compliance with all relevant company policies.

This role will be based in Australia, coverage of the territory will include Australia and New Zealand and require a minimum of 50-60% travel.

Key Responsibilities

Main objectives:

  • Be the trusted scientific partner to key external experts by conducting timely, appropriate and frequent scientific exchanges to enhance the understanding of the scientific and medical value of our products.
  • Execute on stakeholder engagement plans to gather data, develop and share medical insights that contribute to the enhancement of AVROBIO’s key medical messages, plans, and future research.
  • Partner with Clinical Development colleagues to drive clinical trial and overall clinical development success, including identifying principle investigators and advisors, enhancing clinical trial enrollment and appropriately communicating clinical development findings
  • Keep abreast of medical and scientific developments in the LSD field to help identify and critically assess research opportunities and to play a supportive role in the execution of evidence generation plans.
  • Recognize, record and share insights that deepen our understanding of the needs of patients, consumers, regulators, payers, and healthcare providers and proactively contribute towards identifying unmet needs.
  • Maintain effective and appropriate communication among internal stakeholders (Medical Affairs colleagues, Clinical Development and Commercial Operations) while maintaining full compliance with relevant company, industry, legal and regulatory requirements
  • Uses strong knowledge of relevant diseases and disease management protocols, healthcare environment and competitors to articulate the medical and scientific value of our products with external experts.
  • Establishes robust, long-term peer relationships with Key Opinion Leaders and other stakeholder partners
  • Engages with appropriate stakeholders to understand the state of healthcare policies and guidelines as they relate to clinical practices at different levels within responsible region. 
  • Uses defined systems to map, identify, profile, and prioritizes stakeholders in line with the therapeutic area medical plan and looks for opportunities to collaborate and build a value-based partnership addressing the HCPs therapeutic goals.
  • Effectively utilizes the Scientific Engagement Model to plan territory and individual stakeholder (Key Opinion Leaders, payers, HCP, etc.) medical strategy and engagement interaction plans consistent with the Field Base Medical Activity Plan and medical function priorities.
  • Effectively utilizes the Scientific Engagement Model for attending and establishing an AVROBIO Medical presence at relevant scientific congresses, symposia as directed.
  • Organizes educational meetings or local scientific advisory boards when requested.
  • Support speakers training to ensure continued scientific support in the field.
  • Responds to unsolicited request for medical information associated with our development programs and disease state areas.
  • Gathers data and generates insights from stakeholder interactions and provides feedback to the organization.
  • Recognize and collect feedback/reactions from multiple data sources and various stakeholders.
  • Record/report insights and information appropriately, using available mechanisms and tools.
  • Critically and routinely evaluate and discern from the information gained from published studies, and stakeholder interactions to develop key insights that deepen our understanding of the market’s needs and opinions of external stakeholders and therefore contribute to the enhancement of AVROBIO’s scientific messages, plans, strategy, systems, and product development.
  • Maintain awareness of and assesses emerging evidence in the disease area to educate and enhance discussions with key stakeholders.
  • Distribute relevant scientific and medical information and key external insights to internal stakeholders when requested.
  • Collaborate, as directed, with Commercial Operations, Business Development, Regulatory, etc. to facilitate diligence reviews, medical and safety evaluation, product positioning, lifecycle evidence planning, and compliance needs.
  • Contribute to the creation of material for internal and external stakeholders where applicable, following internal policies, and Federal and National Policies as applicable.
Minimum Requirements/ Qualifications
  • A minimum of 5+ years experience as an MSL, with 10+ years biotech/pharma/relevant health care experience overall. Experience in lysosomal storage diseases (or broadly metabolic genetics), rare diseases, and cell or gene therapy strongly preferred.
  • Advanced degree in a technical, scientific, or medical field (MD, Ph.D., Pharm D.) preferred, or other relevant life science degree (RN/MS) with healthcare specialty required.   
  • Clear understanding of the medical practice, clinical decision-making and healthcare systems related to patient care.
  • Demonstrated ability to address educational and research needs through delivery of scientific/evidenced-based data.
  • Demonstrated ability to work on multi-disciplinary teams and manage a significant volume of projects.



  • Exemplary communication and presentation skills.
  • Actively listens to others and is adept at confidently stating expert opinion while respecting the positions of others - can exert diplomacy while standing firm on a position.
  • Utilizes effective, professional communications to cultivate strong working relationships with internal and external colleagues, flexible in own approach to people and situations.
  • Demonstrates effective leadership skills (by example and through accomplishments), steps forward to handle challenges within scope of authority.
  • Deep understanding and knowledge of local regulations and codes of practice for the pharmaceutical industry, particularly as they apply to the non-promotional activities of this role.
  • Demonstrates scientific expertise - stays abreast of data, treatment trends, and new information in the profession and ability to articulate therapeutic knowledge and translate expert feedback into appropriate insights.
  • Knowledge of relevant healthcare systems, the evolving medical landscape, regulatory and payer environment, public health and industry trends.
  • Proficiency in digital tools.

AVROBIO, Inc., a leader in lentiviral-based gene therapies, is a clinical-stage company developing disruptive therapies that have the potential to transform patients’ lives with a single dose. The Company is focused on the development of its gene therapy candidate, AVR‑RD‑01, in Fabry disease, as well as additional gene therapy programs in other lysosomal storage disorders including Gaucher disease, Cystinosis and Pompe disease. AVROBIO’s lentiviral platform has broad potential for other rare and non-rare genetic diseases. AVROBIO is headquartered in Cambridge, MA and has offices in Toronto, ON.

AVROBIO, Inc is an EEO employer